These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 22468630)

  • 21. Oridonin-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma.
    Feng N; Wu P; Li Q; Mei Y; Shi S; Yu J; Xu J; Liu Y; Wang Y
    J Drug Target; 2008 Jul; 16(6):479-85. PubMed ID: 18604660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting.
    Lin A; Chen J; Liu Y; Deng S; Wu Z; Huang Y; Ping Q
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1348-55. PubMed ID: 19832635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
    Sayin B; Somavarapu S; Li XW; Thanou M; Sesardic D; Alpar HO; Senel S
    Int J Pharm; 2008 Nov; 363(1-2):139-48. PubMed ID: 18662762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation and characterization of cationic nanoparticles loaded with Mitomycin C by double emulsion and ionotropic gelation techniques.
    Erdoğar N; Mungan A; Bilensoy E
    J Control Release; 2010 Nov; 148(1):e78-9. PubMed ID: 21529641
    [No Abstract]   [Full Text] [Related]  

  • 25. [Study of the synergy of microwave hyperthermia/intravesical chemotherapy in the prevention of recurrences of superficial tumors of the bladder].
    Mauroy B; Bonnal JL; Prevost B; Chive M; Lhotellier V; Sozanski JP; Vanseymortier L; Stefaniak X
    Prog Urol; 1999 Feb; 9(1):69-80. PubMed ID: 10212955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paclitaxel-loaded gelatin nanoparticles for intravesical bladder cancer therapy.
    Lu Z; Yeh TK; Tsai M; Au JL; Wientjes MG
    Clin Cancer Res; 2004 Nov; 10(22):7677-84. PubMed ID: 15570001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasmid DNA-loaded chitosan/TPP nanoparticles for topical gene delivery.
    Özbaş-Turan S; Akbuğa J
    Drug Deliv; 2011 Apr; 18(3):215-22. PubMed ID: 21226549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery.
    Gan Q; Wang T; Cochrane C; McCarron P
    Colloids Surf B Biointerfaces; 2005 Aug; 44(2-3):65-73. PubMed ID: 16024239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chitosan nanoparticles for controlled delivery of brimonidine tartrate to the ocular membrane.
    Singh KH; Shinde UA
    Pharmazie; 2011 Aug; 66(8):594-9. PubMed ID: 21901982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and in vitro/in vivo anti-cancer evaluation of curcumin-loaded chitosan/poly(butyl cyanoacrylate) nanoparticles.
    Duan J; Zhang Y; Han S; Chen Y; Li B; Liao M; Chen W; Deng X; Zhao J; Huang B
    Int J Pharm; 2010 Nov; 400(1-2):211-20. PubMed ID: 20813175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation and characterization of cationic chitosan-modified poly(D,L-lactide-co-glycolide) copolymer nanospheres as DNA carriers.
    Guan XP; Quan DP; Liao KR; Tao Wang ; Peng Xiang ; Mai KC
    J Biomater Appl; 2008 Jan; 22(4):353-71. PubMed ID: 17494965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and characterization of a new plasmid delivery system based on chitosan-sodium deoxycholate nanoparticles.
    Cadete A; Figueiredo L; Lopes R; Calado CC; Almeida AJ; Gonçalves LM
    Eur J Pharm Sci; 2012 Mar; 45(4):451-8. PubMed ID: 21986445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of intravesical mitomycin C in superficial bladder cancer patients.
    Dalton JT; Wientjes MG; Badalament RA; Drago JR; Au JL
    Cancer Res; 1991 Oct; 51(19):5144-52. PubMed ID: 1913640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Xyloglucan-block-poly(ϵ-caprolactone) copolymer nanoparticles coated with chitosan as biocompatible mucoadhesive drug delivery system.
    Mazzarino L; Otsuka I; Halila S; Bubniak Ldos S; Mazzucco S; Santos-Silva MC; Lemos-Senna E; Borsali R
    Macromol Biosci; 2014 May; 14(5):709-19. PubMed ID: 24469965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimization of epirubicin nanoparticles using experimental design for enhanced intravesical drug delivery.
    Chang LC; Wu SC; Tsai JW; Yu TJ; Tsai TR
    Int J Pharm; 2009 Jul; 376(1-2):195-203. PubMed ID: 19439169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved tumor tissue penetration and tumor cell uptake achieved by delayed charge reversal nanoparticles.
    Gou J; Liang Y; Miao L; Guo W; Chao Y; He H; Zhang Y; Yang J; Wu C; Yin T; Wang Y; Tang X
    Acta Biomater; 2017 Oct; 62():157-166. PubMed ID: 28827183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravesical chemotherapy of high-grade bladder cancer with HTI-286, a synthetic analogue of the marine sponge product hemiasterlin.
    Hadaschik BA; Adomat H; Fazli L; Fradet Y; Andersen RJ; Gleave ME; So AI
    Clin Cancer Res; 2008 Mar; 14(5):1510-8. PubMed ID: 18316576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of cationic nanoparticles of biodegradable copolymers as siRNA delivery system for hepatitis B treatment.
    Wang J; Feng SS; Wang S; Chen ZY
    Int J Pharm; 2010 Nov; 400(1-2):194-200. PubMed ID: 20801205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation and characterization of HA-PEG-PCL intelligent core-corona nanoparticles for delivery of doxorubicin.
    Yadav AK; Mishra P; Jain S; Mishra P; Mishra AK; Agrawal GP
    J Drug Target; 2008 Jul; 16(6):464-78. PubMed ID: 18604659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization.
    Shahnaz G; Vetter A; Barthelmes J; Rahmat D; Laffleur F; Iqbal J; Perera G; Schlocker W; Dünnhaput S; Augustijns P; Bernkop-Schnürch A
    Int J Pharm; 2012 May; 428(1-2):164-70. PubMed ID: 22421322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.